Farajallah Awny Samaan Botros
Chief Medical Officer
Farajallah Awny Samaan Botros has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.
On the most recent filing, Farajallah Awny Samaan Botros is listed as Chief Medical Officer at TAKEDA PHARMACEUTICAL CO LTD. Inside the rolling window, Farajallah Awny Samaan Botros reported no open-market purchases and 1 open-market sale totaling $240K in TAK.
Companies traded
Other insiders at TAK
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$240K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Farajallah Awny Samaan Botros made?
Farajallah Awny Samaan Botros has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Farajallah Awny Samaan Botros trade?
Farajallah Awny Samaan Botros has filed SEC Form 4 disclosures for 1 company, including TAK.
When was Farajallah Awny Samaan Botros's most recent SEC Form 4 filing?
Farajallah Awny Samaan Botros's most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.
What is Farajallah Awny Samaan Botros's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Farajallah Awny Samaan Botros is listed as Chief Medical Officer.
What is Farajallah Awny Samaan Botros's total buy and sell value in the current window?
Inside the rolling retention window, Farajallah Awny Samaan Botros bought $0 and sold $240K based on SEC Form 4 filings.
What was Farajallah Awny Samaan Botros's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 14,006 TAK shares on 2026-08-10, worth $240K, per SEC Form 4 filings.